Microcurrent Therapy

What Is Microcurrent?

Microcurrent therapy delivers electrical current measured in microamperes (µA) — millionths of an ampere. That’s roughly 1,000 times less current than a standard TENS unit, and so small it falls entirely below the threshold of sensation. You cannot feel it — no tingling, no buzzing, no muscle contraction. It operates silently, at the level your cells already communicate.

How it differs from TENS

Your body’s own bioelectricity

This isn’t just theoretical. Research from Min Zhao’s lab at UC Davis — published in Nature in 2006 — identified endogenous electric fields as a prime directional cue for wound healing, controlling cell migration via PI3Kγ and PTEN signalling.^[6] Researchers measuring real human wounds found electric fields of 107–148 mV/mm in healthy adults — and found they’re 48% weaker in elderly adults, correlating directly with slower healing.^[7] Microcurrent therapy’s premise: support those endogenous signals when they’re disrupted or depleted.

How It Works — The Science

Several mechanisms have been proposed and studied at different levels of rigor. Here’s what the evidence supports — with tier labels applied honestly throughout.

Four primary proposed mechanisms of microcurrent at the cellular level. The applied current (µA, left) interacts with ion channels on the cell membrane, triggering downstream effects in the mitochondria, nucleus, and surrounding immune cells.

ATP production and cellular energy

The foundational study in this field was published by Cheng et al. in 1982.^[9] Applying direct current to rat skin tissue, the researchers found up to a 500% increase in ATP production at 100–500 µA, a ~70% increase in protein synthesis, improved membrane transport, and a biphasic dose-response — above 1,000 µA (into TENS range), ATP production actually declined. ATP is the energy currency every cellular repair process depends on.

Important caveat: This is a single in vitro study on rat tissue that has never been directly replicated in transcutaneous human application. It remains the theoretical backbone of microcurrent dosing rationale, but should be read as mechanistic context rather than confirmed human physiology.

Ion channels, calcium signalling, and the dose window

A 2015 study in Nature Communications identified KCNJ15/Kir4.2 — a specific potassium channel — as the molecular sensor for weak extracellular electric fields, explaining how cells detect currents this small at all.^[11] Research on human fibroblasts found that stimulation at 1–10 Hz produces a ~6-fold increase in intracellular calcium — a key repair-signalling messenger — while stimulation at 100 Hz produces nothing.^[12] Frequency matters at the cellular level. Separately, fibroblast galvanotaxis research has identified a biologically relevant intensity window for directed cell migration, converging with the Cheng dose-response to suggest that “more is not more” with microcurrent.^[13]

Gene expression and tissue remodelling

Microcurrent reaches the nucleus. Research has shown that electrical stimulation activates MAPK/ERK1/2 signalling and TGF-β1 release — pathways directly involved in wound closure and tissue remodelling.^[14] At just 10 µA for 90 seconds per day, fibroblasts increase connective tissue repair signals while reducing pro-inflammatory matrix proteins.^[15] These aren’t marginal effects — they represent the kind of transcriptomic activity that underpins organised tissue repair.

Anti-inflammatory effects

Animal models consistently show microcurrent suppressing the TLR4–NFκB inflammatory pathway, reducing TNF-α, IL-1β, and IL-6. Electrical stimulation also promotes M2 macrophage polarisation — shifting immune cells from an inflammatory to a repair-promoting state. Systematic reviews confirm that electrical stimulation increases VEGF, FGF-2, and TGF-β1 in wound models while reducing pro-inflammatory cytokines.^[16]

Wound healing mechanisms

Wound healing is where microcurrent’s mechanistic and clinical evidence converge most clearly. Applied current can restore disrupted endogenous wound fields, direct cell migration via galvanotaxis — cells physically navigate toward the current^[13][17] — stimulate VEGF-A for new blood vessel growth (27–39% increases documented in human wound models^[5]), and promote the myofibroblast transformation needed for wound closure.

What the Research Shows

Here’s the clinical trial evidence — positive findings and null results both. Honesty about where microcurrent works and where it doesn’t is a core principle of this site.

Wound healing — strongest evidence Tier 1–2

Three independent syntheses now converge on the same signal. A pooled analysis and systematic review by Liu et al. (2016) established a positive effect of electrical stimulation on chronic wound healing across multiple study designs.^[1] A 2022 meta-analysis of 8 RCTs (n=337) found microcurrent + standard care significantly outperformed standard care alone: wound surface area reduced by an additional 8.3 cm², healing time faster by 7 days, meaningful pain reduction — no increase in adverse events.^[2] The Cochrane systematic review (20 RCTs, n=913) found electrical stimulation “probably increases the proportion of ulcers healed” at moderate certainty of evidence.^[1c] A 100-patient clinical case series found microcurrent accelerated healing of diabetic foot ulcers, venous leg ulcers, and pressure ulcers as an adjunct to standard care, with significant reductions in both wound area and pain scores.^[18]

On the regulatory side: microcurrent devices fall under 21 CFR 882.5890 — the FDA’s “transcutaneous electrical nerve stimulator for pain relief” category, Class II, 510(k) pathway.^[19] That clearance is specifically for symptomatic pain relief. It is not a blanket approval for wound healing or tissue repair claims — a distinction I maintain throughout this site.

Chronic pain and musculoskeletal support Tier 2

A 2023 network meta-analysis across 54 studies (n=3,045) found microcurrent was the electrophysical agent most likely to be best for fibromyalgia pain (70% probability) and mood (100%).^[3] A 2023 systematic review focused specifically on knee osteoarthritis added another synthesis layer, showing consistent positive signals for knee pain reduction in multiple RCTs.^[20] Individual RCTs show positive results for acute knee pain, back pain (Cohen’s d=0.75), and facial/sinus pain.

A 2021 double-blinded RCT found cranial microcurrent stimulation (25 µA, 8 Hz) significantly reduced tension-type headache intensity, depression scores, and anxiety scores versus sham over two weeks — broadening the pain evidence beyond musculoskeletal applications.^[21]

Important nuance: a 2021 systematic review found placebo effects accounted for approximately 57% of knee pain improvements in microcurrent trials.^[4] The biological effect is real — but smaller than gross outcome measures suggest, and microcurrent does not work for all pain conditions.

Neurological applications — emerging Tier 2–3

An active research frontier. A randomized trial in retinitis pigmentosa and a systematic review of electrical stimulation for visual function found meaningful improvements in visual acuity and visual field in patients with optic neuropathy — a specific and promising finding, though not yet a basis for general neurological claims.^[25][26] Animal models show microcurrent reducing Alzheimer’s-related plaque and neuroinflammation. Human trials are registered and ongoing. I keep this clearly labelled as a frontier area — promising, but early.

FDA classification

Microcurrent devices are regulated under 21 CFR 882.5890 as FDA Class II via 510(k) clearance. Clearance means substantial equivalence to a predicate device — it is not an efficacy approval for any specific condition. The cleared indication is “symptomatic relief of pain.” Wellness devices like iCare fall under the FDA General Wellness Policy and are not classified as medical devices at all. “Cleared” ≠ “approved” — this distinction is maintained across all content on this site.^[19]

One important distinction: general microcurrent research is not the same as FSM-specific research. The evidence discussed on this page covers microcurrent electrical stimulation as a category. FSM uses the same current range but adds specific frequency pairs — and has its own, distinct evidence base. See the FSM article →

How It’s Delivered

In-office methods

• Electrode pads — adhesive pads placed on skin over target tissue
• Wet towels — alligator clips attached to wet towels placed over the treatment area; the water-soaked towel acts as a large conductive pad for broader coverage across the torso, back, or limbs
• Water / bathtub — electrodes rest directly in water with the limb or body submerged; the water itself becomes the conductive medium, allowing uniform current distribution around joints such as hands, feet, and ankles. Commonly used for extremity work and arthritis protocols
• Graphite gloves — worn by practitioner for direct contact over joints and soft tissue
• Probes — targeted point delivery for scars and trigger points

Home-use devices through this practitioner pathway

Two FDA 510(k) cleared devices are available through this practitioner pathway. Both deliver direct microcurrent and require practitioner involvement before purchase.

Contraindications

How Microcurrent Relates to FSM and PEMF

Microcurrent is the foundation. Two related modalities build on the same physiological principles in different directions — and the differences matter for device selection.

• Frequency Specific Microcurrent (FSM) — same current range, but a second channel adds tissue-specific frequency pairs. The premise: different frequencies interact with different tissues selectively. FSM is what most of the prescription devices on this site deliver. What is FSM? →
• PEMF (Pulsed Electromagnetic Fields) — electromagnetic pulses delivered via magnetic induction, not electrode contact. No wet towels, no skin prep. Its own strong evidence base, including FDA approval for bone healing since 1979. What is PEMF? →
• FSM via PEMF — what the iCare platform delivers: FSM frequency protocols through PEMF delivery. Same frequency pairs, different physics. FSM via PEMF — Same Frequencies, Different Delivery →

The distinction between direct current delivery (CustomCare, HoweRT) and PEMF delivery (iCare) has real clinical implications — covered fully in the FSM via PEMF article.